NLRP3 and Stroke: Stroke remains the predominant cause of mortality and persistent impairment globally, with ischemic stroke accounting for approximately 85% of total occurrences.399 Targeting the NLRP3 inflammasome to inhibit pyroptosis has been the dominant strategy for alleviating stroke symptoms in the past few years.